Merck Sharp & Dohme Corp. v. Dr. Reddys Laboratories, Inc. et al
| Merck Sharp & Dohme Corp. |
| Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd. |
| 1:2021cv01033 |
| July 15, 2021 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 27, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 11 NOTICE of Appearance by Stephanie E. O'Byrne on behalf of Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd. (O'Byrne, Stephanie) |
| Filing 10 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent none for Dr. Reddys Laboratories, Ltd.; Corporate Parent Dr. Reddy's Laboratories, Ltd. for Dr. Reddys Laboratories, Inc. filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Moore, David) |
| Filing 9 ANSWER to #1 Complaint, Defenses, and COUNTERCLAIMS against Merck Sharp & Dohme Corp., by Dr. Reddys Laboratories, Ltd., Dr. Reddys Laboratories, Inc..(Moore, David) Modified on 8/25/2021 (nms). |
| Filing 8 DECLARATION of Service on Dr. Reddy's Laboratories, Ltd., by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 8/4/2021 (nms). |
| Filing 7 DECLARATION of Service on Dr. Reddy's Laboratories, Inc., by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 8/4/2021 (nms). |
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Filing 6 Summonses Issued (please complete the top portion of the form and print out for use/service). (srs) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp.. (srs) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (srs) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 06/04/2021. Date of Expiration of Patent: 11/24/2026.Thirty Month Stay Deadline: 12/4/2023. (srs) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (srs) |
| Filing 1 COMPLAINT filed against Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3658305.) - filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(srs) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
